InvestorsHub Logo
Followers 5
Posts 654
Boards Moderated 1
Alias Born 10/11/2014

Re: Rock_nj post# 39

Thursday, 03/05/2015 8:57:51 AM

Thursday, March 05, 2015 8:57:51 AM

Post# of 179

I get it, but why do you think a big price increase is just weeks away? Do they have product announcements coming or something else that is an expected catalyst?



CATALYSTS

From CEO:

Quite simply… the HUGE driver will be purchase orders. In the interim, many investors will see value in the continued, systematic steps we are taking to commercialize these technologies. The securing of additional Board of Director expertise; augmenting our Advisory Board; increasing our strategic relationship with P0S Biosciences; additional joint venture partnerships. These will be key drivers that will serve as evidence that we are approaching the ‘promised land’ of Purchase Orders.

They are now (more than) enthusiastic supporters of our omega technologies and have begun introducing us to their 600+ global clients. Obviously, P0S Biosciences would not put their 35+ year reputation at stake if they did not understand and believe in the science.

Not only does P0S ‘know’ it works, they assisted in commercializing the process so they in fact completely understand the science, process and potential. It is for this reason that they approached NSP in regards to representing the omega technologies and products globally. Our relationship with P0S Biosciences continues to grow. They have invited us to their facilities to discuss growing the business relationship with additional JV opportunities.



We’ve gone through this Q&A without talking about cannabinoids, even though that’s what half the industry is focused on. That’s by design. Yours isn’t a weed company, is it? To me, it’s a full on biotech play with weedy origins that has been taken over by people in big boy pants.

Agreed. Although we started as a Canabis Sativa (starting in industrial hemp ) company, we have expanded to cannabinoids. However, we are not limited to cannabis sativa. Our technologies allow us to enter multiple markets, with multiple products in a variety of distribution channels.

The possibilities of applying your tech to CBDs are potentially game-changing, am I right? Right now, to create the CBDs that MMJ patients need for their ailments can cost a lot of money in source materials, processing, hydro, security, and you’re navigating a regulatory maze just to be allowed to do business. In fact, a court in BC just heard from a witness in the Allard marijuana case that he needs 98 plants just to medicate himself.

But if you can get the exact same CBDs out of industrial hemp, without any THC (which is what makes regulators crazy), and hemp is – what – 1/400th of the price of medical marijuana? And it grows outside with no security or hydro necessary? You could conceivably make the entire MMJ industry more trouble than it’s worth, overnight.

Watch this space.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NSP News